Imperial College London Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
University of Sheffield Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Reading Featured PhD Programmes
"pharmacology"×
10 miles

Pharmacy / Pharmaceutics (pharmacology) PhD Projects, Programs & Scholarships

We have 22 Pharmacy / Pharmaceutics (pharmacology) PhD Projects, Programs & Scholarships

  • "pharmacology" ×
  • Pharmacy / Pharmaceutics×
  • clear all
Order by 
Showing 1 to 22 of 22
  Pharmacology of soft nanomaterials: investigating nanoparticle-cell interaction
  Dr M Jones
Applications accepted all year round

Funding Type

PhD Type

Research into so-called ’soft’ or organic nanomaterials has been thriving with a wide variety of compositions being explored for pharmaceutical applications.
  Neuropeptide Research - PhD Opportunity at a World Class Institution
  Dr M Muttenthaler, Assoc Prof C Schroeder, Assoc Prof I Vetter
Applications accepted all year round

Funding Type

PhD Type

We are seeking talented and highly motivated PhD candidates for the following multidisciplinary project. Neuropeptides are key mediators in many biological functions and understanding their interaction with target proteins is fundamental to unravel the underlying mechanism of diseases.
  Pharmacoepidemiological study to systematically investigate drug-related adverse events in older people
  Dr P Nishtala
Applications accepted all year round

Funding Type

PhD Type

A self-funded PhD studentship is available under the supervision of Dr Prasad Nishtala at the University of Bath. This is a collaborative project which will involve working with Dr Hamish Jamieson from the Big Data and Ageing Research Group at Christchurch, NZ.
  Predictive analytics to facilitate shared decision making in advanced cancers: The importance of communicating risk to advanced cancer patients
  Dr A Hopkins, Prof MJ Sorich
Applications accepted all year round

Funding Type

PhD Type

Project Title. Predictive analytics to facilitate shared decision making in advanced cancers. The importance of communicating risk to advanced cancer patients.
  Overcoming drug resistance in cancer using nano-encapsulated combination therapies
  Dr M Jones
Applications accepted all year round

Funding Type

PhD Type

Despite advances in cancer treatment, the development of drug resistance remains a major issue affecting long term patient survival.
  Therapeutic resolution of Myodysplastic Syndrome (MDS)
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Dr K Pors
Applications accepted all year round

Funding Type

PhD Type

Myelodysplastic syndromes (MDS) are the most common adult myeloid malignancy in the UK and it has been estimated that around 8,000 and 40,000 new cases are diagnosed each year in the UK and USA, respectively.
  Therapeutic resolution of pulmonary arterial hypertension (PAH) by natural products
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Prof C Wright
Applications accepted all year round

Funding Type

PhD Type

Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death.
  How does the vascular matrix environment influence platelet activation?
  Dr S Calaminus
Application Deadline: 31 March 2020

Funding Type

PhD Type

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries.
  Identification of novel glucose-dependent alterations responsible for platelet dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr F Rivero
Application Deadline: 31 March 2020

Funding Type

PhD Type

Type 2 diabetes mellitus (T2DM) is a growing global healthcare problem. Clinical findings suggest that more than 70% of patients with T2DM will die of cardiovascular diseases (CVDs) including heart attack and stroke.
  Identification of novel glucose-dependent alterations responsible for vascular dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr R Sturmey
Application Deadline: 31 March 2020

Funding Type

PhD Type

Diabetes is a growing global healthcare problem. The majority of people living with diabetes have Type 2 diabetes mellitus (T2DM), characterised by a resistance of the body to the action of insulin.
  Modulation of platelet-mediated innate immune responses in chronic lymphocytic leukaemia
  Dr M Arman
Application Deadline: 31 March 2020

Funding Type

PhD Type

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in the Western World. B-cell receptor-induced intracellular signals are critical for the survival of leukaemia cells and disruption of this pathway by the Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib is a highly effective CLL therapy.
  Precision-cut lung slices to investigate the effect of human rhinovirus on cough and airway inflammation
  Dr L Sadofsky
Application Deadline: 31 March 2020

Funding Type

PhD Type

The human Rhinovirus (RV) is the major cause of the common cold. There are no current treatments or vaccines for the virus other than over the counter preparations to alleviate symptoms.
  Re-purposing diabetes medicines to manage bleeding complications in myeloproliferative neoplasms.
  Prof Tim Palmer, Dr D Allsup
Application Deadline: 31 March 2020

Funding Type

PhD Type

Myeloproliferative neoplasms (MPNs) are a group of three related blood cancers in which the bone marrow overproduces one of the three cellular components of blood (erythrocytes, leukocytes and platelets).
  Analysing the factors that regulate expression of blood-brain barrier drug transporter proteins
  Dr J L Penny, Dr C Demonacos
Applications accepted all year round

Funding Type

PhD Type

In order to treat diseases associated with the central nervous system (CNS), e.g. cancer, Parkinson’s disease, depression, it is essential for therapeutic drugs to be able to penetrate into the brain.
  Development of mechanistic models for analysis and interpretation of cough challenge test data.
  Dr K Ogungbenro, Prof L Aarons, Prof J Smith
Applications accepted all year round

Funding Type

PhD Type

Cough is the most common reason for which medical advice is sought both at primary and secondary health care levels.
  Applying human drug discovery approaches to kauri die back disease
  Prof M Glass
Applications accepted all year round

Funding Type

PhD Type

Phytophthora agathidicida is currently threatening New Zealand’s most iconic tree, the kauri. Current efforts to halt its spread through New Zealand forests are failing.
  New Dimensions in Cannabinoid Receptor 2 Therapeutic Development: Exploring Spatial and Temporal Signalling Bias
  Dr N Grimsey
Applications accepted all year round

Funding Type

PhD Type

Compounds derived from Cannabis sativa, termed “cannabinoids”, primarily exert their effects via two G protein-coupled receptors (GPCRs), Cannabinoid Receptors 1 and 2 (CB1 and CB2).
  A novel approach to the development of an antimuscarinic potency tool and measuring anticholinergic burden in older people
  Dr P Nishtala
Applications accepted all year round

Funding Type

PhD Type

A self-funded PhD studentship is available under the supervision of Dr Prasad Nishtala at the University of Bath. This is a collaborative project which will involve working with Dr Hamish Jamieson from the Big Data and Ageing Research Group at Christchurch.
  Examining the longitudinal associations of polypharmacy and frailty with functional decline in older people with multimorbidity
  Dr P Nishtala
Applications accepted all year round

Funding Type

PhD Type

A self-funded PhD studentship is available under the supervision of Dr Prasad Nishtala at the University of Bath. This is a collaborative project, which will involve working with Dr Hamish Jamieson from the Big Data and Ageing Research Group at Christchurch and Dr Danijela Gnjidic at the University of Sydney.
  Is there a switch between prostamides and prostaglandins in women with dysmenorrhoea and heavy menstrual bleeding?
  Prof K Marshall, Dr D Fischer, Prof A Nicolaou
Applications accepted all year round

Funding Type

PhD Type

Dysmenorrhoea, painful menstrual cramps, and heavy menstrual bleeding are common debilitating symptoms in women with or without an underlying pelvic pathology.
  Carbohydrate analysis for biomedical applications.
  Dr S Allman
Applications accepted all year round

Funding Type

PhD Type

Changes in the patterns of carbohydrates produced by the cell can provide insights into disease states, revealing perturbations and differences in cellular metabolic processes.
  Developing novel formulations and materials for transmucosal drug delivery
  Prof V Khutoryanskiy
Applications accepted all year round

Funding Type

PhD Type

Mucosal routes of drug administration offer numerous advantages including ease of application, non-invasive nature and sometimes possibility of targeting particular organs.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.